# Pizarra — PT-pseudo_3f75ae876abe (task 1)

## [1] CASE FILE

**INTAKE** — *the patient record, verbatim; adds no interpretation*

The structured clinical record below is the read-only panel the urologist sees up front, exactly as it arrives in this patient's record. The documents it refers to are masked and must be retrieved.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_3f75ae876abe
Task: 1

Encounter: Urology - outpatient on 01 Jan 2025.
Referrer: Dr. L. Smits (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 69-year-old male
  - PSA: 16.8 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.846 ng/mL²
  - PSA velocity: 3.33 ng/mL/yr
  - Prior PSA: 11.0 ng/mL
  - Prostate volume: 19.86 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.87284654 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 16.8 ng/mL. PI-RADS 5. PSAD 0.85. Prostate volume 20 mL. csPCa 0.87.

Vitals: weight 91 kg, height 177 cm, BMI 29.0, BP 111/83 mmHg, HR 66 bpm. Smoking: Current smoker (15 pack-yr).

Chief complaint: Persistent prostate-specific antigen elevation alongside recent multiparametric magnetic resonance imaging results prompted this visit.

History: At sixty-nine years of age, he attends this consultation for ongoing evaluation. His prior biopsy bucket "None". He is a retired truck driver who lives alone despite being married. Current smoker (15 pack-yr). Lower urinary tract symptoms have persisted for several years, currently registering a sixteen-point score on the International Prostate Symptom Score, with no history of hematuria or acute urinary retention. His daily routine remains largely sedentary, supplemented by chair-based exercises and a modest alcohol intake of approximately six units each week. Past medical encounters include a standard cataract evaluation at ophthalmology and a routine thyroid screen with endocrinology. A minor knee sprain sustained from a slip at home last winter has fully resolved. He regularly travels more than sixty minutes by train to reach the clinic and has requested extended time for this appointment.

Physical examination: DRE — texture: smooth and symmetric; mobility: unrestricted; asymmetry: absent. The gentleman appears well-nourished and shows no signs of acute distress. Auscultation confirms clear lung fields and a regular cardiac rhythm. Hemodynamics remain stable, recording a blood pressure of 111/83 mmHg and a heart rate of 66 beats per minute.

Patient info: retired truck driver; Married; Lives alone.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 6 units / week; exercise Limited mobility — chair-based exercises only; IPSS score: 16/35 (moderate LUTS).

Recent other appointments: Ophthalmology — cataract review; Endocrine — thyroid screening.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


[Note for the conference: for a task-1 biopsy decision only FOUR masked documents actually exist on file - the radiology / mpMRI report, the PSA history, the previous notes and the laboratory panel - plus the family-history anamnesis. There is no pathology report to retrieve for this task; the prior-biopsy status shown in the panel above is all the pathology information on record.]

## [2] INITIAL RECOMMENDATION (statistical prior)

**EXPERT-PRIOR** — *statistical expert; k-NN over 8 structured variables of THIS prompt only, trained on 91 labelled cases, leave-one-out honest*

A basic classifier, whose sole purpose is to provide a suggestion, produces this result along with its associated uncertainty. The purpose of this decision is to use it as an initial reference point for discussing the results.

SUGGESTION: BIOPSY
  p(biopsy = yes) = 0.88 +/- 0.11   (95% CI 0.60-1.00)

Where the uncertainty comes from:
  - aleatoric  dA = 0.10  (the nearest labelled cases disagree with each other)
  - epistemic  dA = 0.04  (few labelled cases resemble this one)
  - 7.6 effective neighbours out of 10; 5 of the 5 closest labelled cases were biopsied
  - 80%-coverage conformal set: {yes}

TIER 'firm': A +/- 1.96*dA does not cross the 0.5 threshold. On the 91 labelled cases this tier was never wrong, but it only covered 17 of them, so the 95% CI on that accuracy still reaches down to ~0.75. Treat it as a strong prior that should only be overturned by explicit contradicting evidence.

Variables it actually read (from the visible panel only, no documents retrieved):
  pirads=5.0, bx_ord=0.0, psa=16.8, age=69.0, psad=0.846, dre_ord=0.0, vol=19.86, n_pmhx=0.0
  missing / not evaluable: none

Out-of-fold performance of this recommender on the 91 labelled cases (5x5 CV):
  accuracy 0.703, balanced accuracy 0.662, AUC 0.75, ECE 0.095.
It is right about 7 times out of 10 overall. It is NOT an oracle and it has never seen the
radiology report, the PSA trajectory, the laboratory panel or the previous notes.

## [3] GUIDELINE CRITERION FOR THIS SITUATION

**EXPERT-PROTOCOL** — *protocol expert; applies the guideline criterion for this patient's clinical situation*

CLINICAL SITUATION: biopsy-naive.

CRITERION VERDICT: BIOPSY.

The criterion: Biopsy when the mpMRI shows a PI-RADS 3 or higher lesion; defer when PI-RADS is 1-2.

In the labelled cohort this criterion matched the reading urologist in every one of the 24 biopsy-naive cases (20 of them PI-RADS 4-5 and biopsied, 4 of them PI-RADS 2 or unreadable and deferred).

Track record of this criterion on the labelled cohort: 24 of 24 cases matched the reading urologist. Departing from it needs a specific finding from a retrieved document, named explicitly - not a restatement of the panel numbers it already used.

Like the statistical prior, this expert has read ONLY the visible panel. It has not seen the
mpMRI prose, the PSA trajectory, the previous notes or the laboratory panel.

## [4] GAPS AND DOUBTS

**LLM-1-GAP-ANALYST** — *raises doubt only; has no access to clinical documents and issues no recommendation*

WHAT THE PRIOR CANNOT SEE
The statistical prior only considered the visible panel data (PI-RADS=5, PSA=16.8, Age=69, PSA Density=0.846, DRE=Normal, Volume=19.86 mL, Prior Biopsy=None) and failed to incorporate the PSA velocity (3.33 ng/mL/yr) or the csPCa predicted probability (0.87284654).
WHY THE SUGGESTION COULD BE WRONG
The prior suggested biopsy based on a high probability (0.88), but this ignores the potential for overdiagnosis, as the guideline search indicates that biopsy can miss ISUP $\ge 2$ cancer in biopsy-naive men, even with high PI-RADS scores. The prior's high confidence might be based on the PI-RADS 5 alone, without accounting for the PSA trajectory or the risk-adapted matrix.
WHAT TO RETRIEVE, AND WHAT WOULD CHANGE THE ANSWER
radiology report - does the lesion compare with a previous MRI? - if it is unchanged the case for sampling weakens; if new or larger it strengthens
PSA history - to assess the trend beyond the headline value of 16.8 ng/mL
laboratory panel - to see if PSA density or other markers provide context
previous GP / urology notes - to see if prior LUTS or other risk factors were documented
GUIDELINE ANCHOR
The guideline search indicates that a PI-RADS $\ge 3$ triggers biopsy, but this decision comes with the trade-off of missing some ISUP $\ge 2$ cancers in biopsy-naive men.

## [5] EVIDENCE REPORT

**LLM-2-EVIDENCE** — *the only participant who retrieved documents; reports findings, not verdicts*

RETRIEVED
get_mri_report
{"case_id": "PT-pseudo_3f75ae876abe", "radiology_report": "Subject: Prostate Multiparametric MRI\nFacility: UMCG Groningen\nDate: 28 December 2024\nClinical indication: Evaluation of rising PSA (16.8 ng/mL) and moderate lower urinary tract symptoms.\n\nFINDINGS:\nProstate volume: 19.86 mL.\nT2-weighted sequences highlight a well-circumscribed hypointense focus in the right anterior mid-gland, spanning roughly 12 x 9 x 10 mm. Marginal capsular bulging is present without frank extraprostatic extension.\nDiffusion-weighted imaging exhibits marked signal restriction alongside correspondingly low ADC values. Dynamic contrast-enhanced sequences demonstrate early, focal enhancement localized to the lesion.\nSeminal vesicles maintain normal size and signal characteristics. No suspicious lymphadenopathy or osseous abnormalities are detected.\n\nIMPRESSION:\nPI-RADS 5 lesion in the right anterior mid-gland.\nProstate volume 19.86 mL.\nPSAD 0.846 ng/mL/mL.\ncsPCa predicted probability 0.87284654."}
get_psa_trend
{"case_id": "PT-pseudo_3f75ae876abe", "psa_trend": [{"date": "Nov 2022", "val": 2.8}, {"date": "Jul 2023", "val": 5.1}, {"date": "Apr 2024", "val": 9.2}, {"date": "Jan 2025", "val": 16.8}]}
get_previous_notes
{"case_id": "PT-pseudo_3f75ae876abe", "previous_notes": [{"date": "11 Jul 2023", "author": "Dr. L. Smits (GP)", "text": "Prostate-specific antigen concentrations rose from 7.4 ng/mL during November 2022 to 10.0 ng/mL on recent assessment. Digital rectal examination remained unremarkable. Lower urinary tract symptoms are moderate, absent any hematuria or unexplained weight loss."}, {"date": "12 Jan 2023", "author": "Dr. L. Smits (GP)", "text": "An initial prostate-specific antigen reading of 7.4 ng/mL was recorded in November 2022. Sustained elevation above laboratory reference limits was confirmed during a January 2023 follow-up. He is a retired truck driver experiencing moderate lower urinary tract symptoms without acute urinary retention."}]}
get_lab_results
{"case_id": "PT-pseudo_3f75ae876abe", "laboratory_results": [{"name": "PSA", "val": "16.8 ng/mL", "date": "25 Nov 2024", "flag": "H"}, {"name": "Free PSA", "val": "3.92 ng/mL", "date": "25 Nov 2024", "flag": ""}, {"name": "%Free PSA", "val": "23%", "date": "25 Nov 2024", "flag": ""}, {"name": "Haemoglobin", "val": "15.6 g/dL", "date": "25 Nov 2024", "flag": ""}, {"name": "WBC", "val": "5.7 x10^9/L", "date": "25 Nov 2024", "flag": ""}, {"name": "Platelets", "val": "174 x10^9/L", "date": "25 Nov 2024", "flag": ""}, {"name": "Creatinine", "val": "93 umol/L", "date": "25 Nov 2024", "flag": ""}, {"name": "eGFR", "val": ">60 mL/min/1.73m2", "date": "25 Nov 2024", "flag": ""}, {"name": "Testosterone", "val": "11.7 nmol/L", "date": "25 Nov 2024", "flag": ""}, {"name": "Alkaline phosphatase", "val": "65 U/L", "date": "25 Nov 2024", "flag": ""}, {"name": "LDH", "val": "158 U/L", "date": "25 Nov 2024", "flag": ""}]}

NOT RETRIEVED
The family history of prostate cancer was not retrieved, which is not required for this decision.

WHAT THE EVIDENCE SUPPORTS
FOR sampling this patient now:
- mpMRI report: PI-RADS 5 lesion in the right anterior mid-gland.
- PSA trend: Rising trend from 2.8 ng/mL (Nov 2022) to 16.8 ng/mL (Jan 2025).
- csPCa predicted probability: 0.87284654.

AGAINST sampling this patient now:
- mpMRI report: Lesion is described as well-circumscribed with no frank extraprostatic extension.

WHERE THIS LEANS
The evidence strongly supports biopsy due to the PI-RADS 5 score and the significant rising PSA velocity, which aligns with the expert protocol's criterion.

[Sections actually revealed in this consultation: radiology_report, psa_trend, previous_notes, laboratory_results. Tools executed: get_lab_results, get_mri_report, get_previous_notes, get_psa_trend.]

## [6] IMAGE-EMBEDDING PREDICTOR

**EXPERT-IMAGE** — *image-embedding expert; frozen foundation-model MRI vectors behind a trained head*

Frozen foundation-model embeddings on file for this patient: MRI image (1 vector).
The raw vectors are never shown; only a compact score would be.

No calibrated head is deployed for the biopsy decision, so no score was produced. The probe that measured this modality for task 1 reported AUC 0.43 (at or below chance), which is why nothing is being asserted here.

Bottom line for the chair: the image-embedding route contributes NO usable evidence for this
biopsy decision. Decide on the structured panel, the retrieved documents and the guidelines.
Do not cite imaging-embedding support in the reasoning, and do not let the absence of a score
count as a negative finding.

## [7] FINAL DECISION AND FORM

**LLM-3-CHAIR** — *chairs the conference; the only participant who decides*

FINAL DECISION: BIOPSY   (confidence: clear)

The decision is to proceed with biopsy because the mpMRI identified a PI-RADS 5 lesion, which is the primary driver according to the expert protocol. This finding is supported by the retrieved mpMRI report detailing a well-circumscribed lesion. The PSA trajectory, showing a significant rise from 2.8 ng/mL to 16.8 ng/mL, further supports the need for tissue sampling. The statistical prior also suggested biopsy, and the evidence converges on this recommendation.

Variables that carried weight: age=important, dre=noted, psa=decisive, vol=noted, psad=important, pirads=decisive, comorbidity=noted
Sections revealed: radiology_report, psa_trend, previous_notes, laboratory_results
